PremiumCompany AnnouncementsSotera Health Q1 2025 Earnings Call Highlights Growth and Challenges Sotera Health Reports Mixed Q1 2025 Results Sotera Health price target raised to $15 from $12 at Barclays PremiumThe FlySotera Health price target lowered to $12 from $16 at Barclays Sotera Health Settles Ethylene Oxide Claims for $30.9M Sotera’s Nelson Labs launches rapid sterility testing to expedite results PremiumThe FlySotera Health sees FY25 adjusted EPS 70c-76c, consensus 78c Sotera Health price target lowered to $17 from $18 at Barclays Sotera Health Projects 5% Revenue Growth for 2024 
